Bridgewater-based Cosette Pharmaceuticals announced Feb. 20 it entered into an agreement to acquire Mayne Pharma Group Ltd. in a $430 million deal. Mayne is an Australian-headquartered specialty ...
BRIDGEWATER, N.J., February 20, 2025--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it ...
Australia’s leading independent law firm, Corrs Chambers Westgarth, has advised Cosette Pharmaceuticals, Inc (Cosette) on its pending A$672 million acquisition of Mayne Pharma Group Limited (Mayne) ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results